These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21697281)

  • 1. Systemic cancer therapy with a small molecule agonist of toll-like receptor 7 can be improved by circumventing TLR tolerance.
    Bourquin C; Hotz C; Noerenberg D; Voelkl A; Heidegger S; Roetzer LC; Storch B; Sandholzer N; Wurzenberger C; Anz D; Endres S
    Cancer Res; 2011 Aug; 71(15):5123-33. PubMed ID: 21697281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists.
    Hamm S; Rath S; Michel S; Baumgartner R
    J Immunotoxicol; 2009 Dec; 6(4):257-65. PubMed ID: 19848448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
    Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
    J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells.
    Roelofs MF; Joosten LA; Abdollahi-Roodsaz S; van Lieshout AW; Sprong T; van den Hoogen FH; van den Berg WB; Radstake TR
    Arthritis Rheum; 2005 Aug; 52(8):2313-22. PubMed ID: 16052591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T; Barton GM; Flavell RA; Medzhitov R
    Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TLR7 agonist R848 alleviates allergic inflammation by targeting invariant NKT cells to produce IFN-gamma.
    Grela F; Aumeunier A; Bardel E; Van LP; Bourgeois E; Vanoirbeek J; Leite-de-Moraes M; Schneider E; Dy M; Herbelin A; Thieblemont N
    J Immunol; 2011 Jan; 186(1):284-90. PubMed ID: 21131420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists.
    Kandimalla ER; Struthers M; Bett AJ; Wisniewski T; Dubey SA; Jiang W; Precopio M; Sun Z; Wang H; Lan T; Agrawal S; Casimiro DR
    Cell Immunol; 2011; 270(2):126-34. PubMed ID: 21570062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CL097, a TLR7/8 ligand, inhibits TLR-4--dependent activation of IRAK-M and BCL-3 expression.
    Petricevic B; Wessner B; Sachet M; Vrbanec D; Spittler A; Bergmann M
    Shock; 2009 Nov; 32(5):484-90. PubMed ID: 19333135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines.
    Edwards AD; Diebold SS; Slack EM; Tomizawa H; Hemmi H; Kaisho T; Akira S; Reis e Sousa C
    Eur J Immunol; 2003 Apr; 33(4):827-33. PubMed ID: 12672047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9.
    Hoshino K; Sugiyama T; Matsumoto M; Tanaka T; Saito M; Hemmi H; Ohara O; Akira S; Kaisho T
    Nature; 2006 Apr; 440(7086):949-53. PubMed ID: 16612387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.
    Lombardi V; Van Overtvelt L; Horiot S; Moingeon P
    J Immunol; 2009 Mar; 182(6):3372-9. PubMed ID: 19265114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7.
    Sugiyama T; Hoshino K; Saito M; Yano T; Sasaki I; Yamazaki C; Akira S; Kaisho T
    Int Immunol; 2008 Jan; 20(1):1-9. PubMed ID: 17981792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling through TLR7 enhances the immunosuppressive activity of murine CD4+CD25+ T regulatory cells.
    Forward NA; Furlong SJ; Yang Y; Lin TJ; Hoskin DW
    J Leukoc Biol; 2010 Jan; 87(1):117-25. PubMed ID: 19843574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR7 tolerance is independent of the type I IFN pathway and leads to loss of anti-tumor efficacy in mice.
    Koga-Yamakawa E; Murata M; Dovedi SJ; Wilkinson RW; Ota Y; Umehara H; Sugaru E; Hirose Y; Harada H; Jewsbury PJ; Yamamoto S; Robinson DT; Li CJ
    Cancer Immunol Immunother; 2015 Oct; 64(10):1229-39. PubMed ID: 26091797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs.
    Hackl D; Loschko J; Sparwasser T; Reindl W; Krug AB
    Eur J Immunol; 2011 May; 41(5):1334-43. PubMed ID: 21469103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor Activity of TLR7 Is Potentiated by CD200R Antibody Leading to Changes in the Tumor Microenvironment.
    Pilch Z; Tonecka K; Braniewska A; Sas Z; Skorzynski M; Boon L; Golab J; Meyaard L; Rygiel TP
    Cancer Immunol Res; 2018 Aug; 6(8):930-940. PubMed ID: 30021725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical imiquimod treatment prevents UV-light induced loss of contact hypersensitivity and immune tolerance.
    Thatcher TH; Luzina I; Fishelevich R; Tomai MA; Miller RL; Gaspari AA
    J Invest Dermatol; 2006 Apr; 126(4):821-31. PubMed ID: 16439962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent Toll-like receptor 7 stimulation induces behavioral and molecular innate immune tolerance.
    Michaelis KA; Norgard MA; Levasseur PR; Olson B; Burfeind KG; Buenafe AC; Zhu X; Jeng S; McWeeney SK; Marks DL
    Brain Behav Immun; 2019 Nov; 82():338-353. PubMed ID: 31499172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 7 cooperates with IL-4 in activated B cells through antigen receptor or CD38 and induces class switch recombination and IgG1 production.
    Tsukamoto Y; Nagai Y; Kariyone A; Shibata T; Kaisho T; Akira S; Miyake K; Takatsu K
    Mol Immunol; 2009 Apr; 46(7):1278-88. PubMed ID: 19157556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.